Esperion Therapeutics
ESPR
#6683
Rank
NZ$1.39 B
Marketcap
NZ$5.40
Share price
0.00%
Change (1 day)
114.39%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2026 (TTM): NZ$0.13 Billion

According to Esperion Therapeutics's latest financial reports the company's current earnings are NZ$0.41 Billion. In 2025 the company made an earning of NZ$0.10 Billion, an increase over its 2024 earnings that were of NZ$12.74 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.13 B25.92%
2025 NZ$0.10 B749.49%
2024 NZ$12.74 M-104.99%
2023 -NZ$0.26 Billion-15.03%
2022 -NZ$0.31 Billion-20.61%
2021 -NZ$0.38 Billion84.28%
2020 -NZ$0.21 Billion35.75%
2019 -NZ$0.16 Billion-55.71%
2018 -NZ$0.35 Billion19.57%
2017 -NZ$0.29 Billion125.39%
2016 -NZ$0.13 Billion51.43%
2015 -NZ$83.68 Million36.45%
2014 -NZ$61.33 Million43.55%
2013 -NZ$42.72 Million145.26%
2012 -NZ$17.42 Million
2002 -NZ$49.66 Million-7.81%
2001 -NZ$53.87 Million15.03%
2000 -NZ$46.83 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$17.98 B 13,240.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$8.75 B 6,395.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-NZ$0.92 Billion-775.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-NZ$44.32 Million-132.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$0.32 M-99.76%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.65 B 385.70%๐Ÿ‡บ๐Ÿ‡ธ USA